Bladder Cancer


Principal Investigator:  Dr. Brant Inman
Hospital:  London Health Sciences Centre - Victoria Hospital

TLD-1433-2: A phase II clinical study of intravesical photodynamic therapy in patients with BCG-unresponsive non-muscle invasive bladder cancer (“NMIBC”) or patients who are intolerant to BCG therapy (“Study II”)
Study coordinator: Wendy Shoff: 519.685.8500 x57350 (wendy.shoff@lhsc.on.ca) 
Details: https://clinicaltrials.gov/study/NCT03945162 
Status: Accruing


Principal Investigator:  Dr. Brant Inman
Hospital:  London Health Sciences Centre - Victoria Hospital

PIVOT-006: A Phase 3, Randomized Study of CG0070 versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT)

Study coordinator: Wendy Shoff · Details: https://clinicaltrials.gov/study/NCT06111235 
Status: CLOSED

 

Site Principal Investigator:  Dr. Melissa Huynh
Hospital:  London Health Sciences Centre - Victoria Hospital

MODERN: An integrated phase 2/3 and phase 3 trial of MRD-based optimization of adjuvant therapy in urothelial cancer

Study Coordinators: Stephen Mardell and Kaydee Connors
    Stephen Mardell 519.685.8500 x58448 (stephen.mardell@lhsc.on.ca) 
    Kaydee Connors 519.685.8500 x56366 (kaydee.connors@lhsc.on.ca) 
Details:  A urothelial bladder cancer clinical trial - BLC6 | Canadian Cancer Trials Group
Status: Accruing 


Principal Investigator:  Dr. Nicholas Power
Hospital:  London Health Sciences Centre - Victoria Hospital

STENT-OPT: A feasibility randomized controlled trial evaluating early vs late stent removal following radical cystectomy and ildeal conduit formation for bladder cancer 

Study Coordinator: Kaydee Connors: 519.685.8500 x56366 (kaydee.connors@lhsc.on.ca) 
Status: Accruing 

 

Principal Investigator:  Dr. Melissa Huynh
Hospital:  London Health Sciences Centre - Victoria Hospital

BicaBCa: A phase II randomized trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer NCT06595446

Study Coordinator: Kaydee Connors: 519.685.8500 x56366 (kaydee.connors@lhsc.on.ca) 
Status: Accruing 


Coming Soon:

Principal Investigator:  Dr. Brant Inman
Hospital:  London Health Sciences Centre - Victoria Hospital

CORE-008: A phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) NCT06567743  

Study Coordinators: Wendy Shoff and Kaydee Connors
     Wendy Shoff:  519.685.8500 x57350 (wendy.shoff@lhsc.on.ca) 
     Kaydee Connors: 519.685.8500 x56366 (kaydee.connors@lhsc.on.ca) 
Status: Coming Soon